CbdMD Historical Cash Flow

YCBD Stock  USD 0.43  0.03  6.52%   
Analysis of CbdMD cash flow over time is an excellent tool to project cbdMD Inc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Sale Purchase Of Stock of 113.4 K or Depreciation of 3.5 M as it is a great indicator of CbdMD ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining cbdMD Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether cbdMD Inc is a good buy for the upcoming year.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

About CbdMD Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in CbdMD balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which CbdMD's non-liquid assets can be easily converted into cash.

CbdMD Cash Flow Chart

At present, CbdMD's Change To Inventory is projected to increase significantly based on the last few years of reporting. The current year's Investments is expected to grow to about 848.2 K, whereas Change In Cash is projected to grow to (4.2 M).

Capital Expenditures

Capital Expenditures are funds used by cbdMD Inc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of CbdMD operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most accounts from CbdMD's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into cbdMD Inc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
At present, CbdMD's Change To Inventory is projected to increase significantly based on the last few years of reporting. The current year's Investments is expected to grow to about 848.2 K, whereas Change In Cash is projected to grow to (4.2 M).
 2021 2022 2023 2024 (projected)
Capital Expenditures688.7K297.5K342.2K325.1K
Depreciation3.0M2.9M3.4M3.5M

CbdMD cash flow statement Correlations

-0.31-0.36-0.56-0.05-0.73-0.22-0.4-0.30.23-0.18-0.410.14-0.26-0.3-0.4-0.460.060.2
-0.31-0.440.450.660.47-0.24-0.090.39-0.02-0.05-0.52-0.69-0.190.12-0.030.51-0.660.69
-0.36-0.440.22-0.570.270.290.460.19-0.290.020.730.260.590.480.73-0.240.85-0.85
-0.560.450.22-0.30.95-0.49-0.380.94-0.86-0.540.480.140.140.450.750.85-0.010.07
-0.050.66-0.57-0.3-0.160.340.35-0.390.660.55-0.8-0.92-0.13-0.02-0.59-0.11-0.750.67
-0.730.470.270.95-0.16-0.21-0.180.84-0.75-0.40.510.010.150.540.70.82-0.090.05
-0.22-0.240.29-0.490.34-0.210.78-0.620.550.550.05-0.340.120.16-0.26-0.520.02-0.3
-0.4-0.090.46-0.380.35-0.180.78-0.540.610.8-0.04-0.50.460.22-0.05-0.590.21-0.4
-0.30.390.190.94-0.390.84-0.62-0.54-0.91-0.710.420.220.050.430.770.790.070.1
0.23-0.02-0.29-0.860.66-0.750.550.61-0.910.75-0.69-0.54-0.1-0.41-0.77-0.74-0.210.09
-0.18-0.050.02-0.540.55-0.40.550.8-0.710.75-0.32-0.550.50.08-0.36-0.54-0.13-0.02
-0.41-0.520.730.48-0.80.510.05-0.040.42-0.69-0.320.670.370.410.710.280.58-0.65
0.14-0.690.260.14-0.920.01-0.34-0.50.22-0.54-0.550.67-0.14-0.270.260.160.52-0.51
-0.26-0.190.590.14-0.130.150.120.460.05-0.10.50.37-0.140.710.54-0.170.39-0.31
-0.30.120.480.45-0.020.540.160.220.43-0.410.080.41-0.270.710.680.20.11-0.01
-0.4-0.030.730.75-0.590.7-0.26-0.050.77-0.77-0.360.710.260.540.680.360.56-0.43
-0.460.51-0.240.85-0.110.82-0.52-0.590.79-0.74-0.540.280.16-0.170.20.36-0.430.41
0.06-0.660.85-0.01-0.75-0.090.020.210.07-0.21-0.130.580.520.390.110.56-0.43-0.89
0.20.69-0.850.070.670.05-0.3-0.40.10.09-0.02-0.65-0.51-0.31-0.01-0.430.41-0.89
Click cells to compare fundamentals

CbdMD Account Relationship Matchups

CbdMD cash flow statement Accounts

201920202021202220232024 (projected)
Sale Purchase Of Stock19.0M(1.5M)(30.8M)132.6K119.3K113.4K
Change In Cash10.1M11.6M(19.7M)(4.9M)(4.4M)(4.2M)
Total Cashflows From Investing Activities(2.1M)(1.6M)(2.6M)(688.7K)(619.8K)(650.8K)
Other Cashflows From Financing Activities6.0M30.8M(33.4K)(132.6K)(152.5K)(144.9K)
Depreciation720.8K2.3M3.0M2.9M3.4M3.5M
Capital Expenditures1.3M2.3M688.7K297.5K342.2K325.1K
Total Cash From Operating Activities(10.7M)(14.1M)(15.0M)(4.3M)(3.9M)(4.1M)
Net Income12.6M(23.4M)(70.1M)(22.9M)(20.6M)(21.7M)
Total Cash From Financing Activities22.4M28.2M(4.0M)(1.3M)(1.5M)(1.4M)
End Period Cash Flow14.8M26.4M6.7M1.8M2.1M2.0M
Change To Inventory(535.1K)(1.0M)(112.2K)27.4K31.6K33.1K
Investments(250K)(210K)(688.7K)702.5K807.8K848.2K
Stock Based Compensation2.0M2.9M928.8K342.9K394.3K374.6K
Free Cash Flow(12.0M)(16.4M)(15.7M)(4.6M)(4.1M)(4.3M)
Change In Working Capital(184.5K)(2.8M)(2.8M)570.4K656.0K688.8K
Begin Period Cash Flow4.7M14.8M26.4M6.7M7.7M7.9M
Other Non Cash Items(27.1M)7.4M54.0M(184.3K)(211.9K)(201.3K)
Change To Account Receivables514.4K(183.7K)65.5K278.5K320.3K336.3K
Change To Operating Activities(1.1M)(950.7K)(372.3K)(1.2M)(1.3M)(1.4M)
Issuance Of Capital Stock21.2M30.9M15.1M2.5M2.2M2.1M
Change To Netincome40.8M(23.8M)11.1M54.9M63.2M66.3M
Change To Liabilities(568.4K)171.7K(995.7K)(1.6M)(1.4M)(1.4M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CbdMD. If investors know CbdMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CbdMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.90)
Revenue Per Share
7.06
Quarterly Revenue Growth
(0.15)
Return On Assets
(0.16)
Return On Equity
(1.35)
The market value of cbdMD Inc is measured differently than its book value, which is the value of CbdMD that is recorded on the company's balance sheet. Investors also form their own opinion of CbdMD's value that differs from its market value or its book value, called intrinsic value, which is CbdMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CbdMD's market value can be influenced by many factors that don't directly affect CbdMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.